Pioneering Podatric Care: AIMx Podiatry Appoints Dr. Thuy Ho-Ellsworth as CMO

AIMx Podiatry Appoints Dr. Thuy Ho-Ellsworth as Chief Medical Officer

AIMx Podiatry LLC has recently announced the appointment of Dr. Thuy Ho-Ellsworth, DPM, as their new Chief Medical Officer. Recognized for her contributions in biologic medicine and minimally invasive surgery, Dr. Ho-Ellsworth brings a wealth of experience to propel AIMx's mission of advancing podiatric care into the future.

Dr. Ho-Ellsworth founded Align Foot Ankle, a successful practice in Austin, Texas, where she has effectively directed patient-centered care focusing on regenerative therapies and modern surgical techniques since its inception in 2022. This latest role will leverage her 14 years of experience, combined with her commitment to innovative treatments, to help reshape the landscape of podiatric medicine.

AIMx, committed to enhancing patient outcomes, specializes in biologic and regenerative podiatric solutions. The company offers an impressive set of advanced treatments that include Liposana®, a holistic fat restoration therapy, DPMx umbilical cord allografts, and cutting-edge medical-grade peptides. These novel solutions aim to optimize healing processes, improve mobility, and enable healthcare providers to offer superior care that is not contingent on traditional insurance frameworks.

Dr. Ho-Ellsworth is distinguished not only for her clinical expertise but also for her extensive involvement in education and mentorship. She holds board certification in Foot and Reconstructive Rearfoot and Ankle Surgery from the American Board of Foot and Ankle Surgery. Additionally, she is actively engaged as a Fellow with the Academy of Minimally Invasive Foot and Ankle Surgery, and as an Associate Instructor of Minimally Invasive Surgery with the American College of Podiatric Physicians and Surgeons. Her credentials underscore her dedication to pushing the boundaries of podiatric treatment through education and practice development.

Her mantra, “changing the algorithm,” reflects her vision of employing data-driven, personalized solutions to challenge and revolutionize existing treatments within podiatric care. By embracing efficiency, innovation, and sustainable practices, Dr. Ho-Ellsworth aims to raise the bar for patient care, ensuring higher standards prevail in today’s evolving healthcare environment.

John Zagurasky, President of AIMx Podiatry, conveyed his excitement regarding the appointment: "We’re thrilled to have Dr. Thuy Ho-Ellsworth join our team as Chief Medical Officer. Her vision and extensive knowledge in the biologic field are precisely what podiatrists need to thrive amid changing industry dynamics. Her combined passion for clinical excellence and education will drive meaningful advancements in our field."

In her capacity as CMO, Dr. Ho-Ellsworth will oversee clinical strategy, lead product development, and spearhead educational initiatives designed to support progressive podiatrists nationwide. Her leadership is poised to influence how podiatrists practice, enabling them to harness advanced technology and innovative treatments, ultimately improving patient outcomes.

For further information about AIMx Podiatry and its innovative solutions, visit aimxpodiatry.com or contact them via email at [email protected].

About AIMx Podiatry LLC

AIMx Podiatry LLC empowers motivated podiatrists by equipping them with advanced biologics, medical technology, and cash-pay therapies that prioritize tissue repair and optimal patient outcomes. By focusing on sustainable practice growth outside traditional insurance models, AIMx supports providers in elevating care standards and achieving lasting success.